MALIGNANT NEOPLASTIC DISEASE

Clinical trials for MALIGNANT NEOPLASTIC DISEASE explained in plain language.

Never miss a new study

Get alerted when new MALIGNANT NEOPLASTIC DISEASE trials appear

Sign up with your email to follow new studies for MALIGNANT NEOPLASTIC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New pill targets 'undruggable' cancer mutation in advanced tumors

Disease control Ongoing

This trial is testing an experimental pill called MRTX849 (adagrasib) for people with advanced solid tumors that have a specific genetic change called KRAS G12C. The study aims to find safe doses, see how the drug works in the body, and measure if it shrinks tumors. It includes 7…

Matched conditions: MALIGNANT NEOPLASTIC DISEASE

Phase: PHASE1, PHASE2 • Sponsor: Mirati Therapeutics Inc. • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

MALIGNANT NEOPLASTIC DISEASE

Get alerted when new MALIGNANT NEOPLASTIC DISEASE trials appear

New pill targets 'undruggable' cancer mutation in advanced tumors